IGFBP2 and systemic inflammatory response syndrome: Research indicates that patients with systemic inflammatory response syndrome (SIRS) or sepsis exhibit markedly elevated IGFBP-2 levels compared to healthy controls, with these elevations correlating with the need for dialysis, disease severity, and ultimately mortality [39].